Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model

Experimental Neurology

Volumn 189, Issue 1, 2004, Pages 58-65

  Tsuji, Masahiro ^a,b   Wilson, Mary Ann ^a,b   Lange, Mary S ^a   Johnston, Michael V ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain injury; Hypoxia; Ischemia; Minocycline; Mouse; Neonatal; Rat

Indexed keywords

MINOCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE EXACERBATION; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG SCREENING; EXPERIMENTAL MODEL; FEMALE; HISTOLOGY; INJECTION; MALE; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SCORING SYSTEM; THALAMUS;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; MALE; MICE; MICE, INBRED C57BL; MINOCYCLINE; RANDOM ALLOCATION; RATS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 3543073536     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.01.011     Document Type: Article

References (47)

1. Aicardi J. Neurological diseases in the perinatal period. Aicardi J. Diseases of the Nervous System in Childhood. 2nd edition:1998;32-66 Mac Keith Press, London
2. Amin A.R., Attur M.G., Thakker G.D., Patel P.D., Vyas P.R., Patel R.N., Patel I.R., Abramson S.B. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. U. S. A. 93:1996;14014-14019
3. Amin A.R., Patel R.N., Thakker G.D., Lowenstein C.J., Attur M.G., Abramson S.B. Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines. FEBS Lett. 410:1997;259-264
4. Arvin K.L., Han B.H., Du Y., Lin S.Z., Paul S.M., Holtzman D.M. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann. Neurol. 52:2002;54-61
5. Attur M.G., Patel R.N., Patel P.D., Abramson S.B., Amin A.R. Tetracycline up-regulates COX-2 expression and prostaglandin E2 production independent of its effect on nitric oxide. J. Immunol. 162:1999;3160-3167
6. Brogden R.N., Speight T.M., Avery G.S. Minocycline: a review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs. 9:1975;251-291
7. Chen M., Ona V.O., Li M., Ferrante R.J., Fink K.B., Zhu S., Bian J., Guo L., Farrell L.A., Hersch S.M., Hobbs W., Vonsattel J.P., Cha J.H.J., Friedlander R.M. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 6:2000;797-801
8. Chiu A.M., Chuenkongkaew W.L., Cornblath W.T., Trobe J.D., Digre K.B., Dotan S.A., Musson K.H., Eggenberger E.R. Minocycline treatment and pseudotumor cerebri syndrome. Am. J. Ophthalmol. 126:1998;116-121
9. Clark W.M., Calcagno F.A., Gabler W.L., Smith J.R., Coull B.M. Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment. Stroke. 25:1994;1411-1415
10. De Keyser J., Sulter G., Luiten P.G. Clinical trails with neuroprotective drugs in acute ischemic stroke: are we doing the right thing? Trends Neurosci. 22:1999;535-540
11. Dorè S., Otsuka T., Mito T., Sugo N., Hand T., Wu L., Hurn P.D., Traystman R.J., Andreasson K. Neuronal overexpression cyclooxygenase-2 increases cerebral infarction. Ann. Neurol. 54:2003;155-162
12. Du Y., Ma Z., Lin S., Dodel R.C., Gao F., Bales K.R., Triarhou L.C., Chernet E., Perry K.W., Nelson D.L.G., Luecke S., Phebus L.A., Bymaster F.P., Paul S.M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 98:2001;14669-14674
13. Erickson R.P., Bernard O. Studies on neuronal death in the mouse model of Niemann-Pick C disease. J. Neurosci. Res. 68:2002;738-744
14. Flavin M.P. Influence of dexamethasone on neurotoxicity caused by oxygen and glucose deprivation in vitro. Exp. Neurol. 139:1996;34-38
15. Golub L.M., Lee H.M., Ryan M.E., Giannobile W.V., Payne J., Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv. Dent. Res. 12:1998;12-26
16. Goulden V., Glass D., Cunliffe W.J. Safety of long-term high-dose minocycline in the treatment of acne. Br. J. Dermatol. 134:1996;693-695
17. Guerin C., Laterra J., Masnyk T., Golub L.M., Brem H. Selective endothelial growth inhibition by tetracyclines that inhibit collagenase. Biochem. Biophys. Res. Commun. 188:1992;740-745
18. Hamada Y., Hayakawa T., Hattori H., Mikawa T. Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat. Pediatr. Res. 35:1994;10-14
19. Hattori H., Wasterlain C.G. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology. 39:1989;713-718
20. Hayakawa T., Higuchi Y., Nigami H., Hattori H. Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsive effect. Eur. J. Pharmacol. 257:1994;131-136
21. He Y., Appel S., Le W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 909:2001;187-193
22. Ishida A., Trescher W.H., Lange M.S., Johnston M.V. Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev. 23:2001;349-354
23. Johnston M.V., Trescher W.H., Ishida A., Nakajima W. Novel treatments after experimental brain injury. Semin. Neonatol. 5:2000;75-86
24. Johnston M.V., Trescher W.H., Ishida A., Nakajima W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res. 49:2001;735-741
25. Klein N.C., Cunha B.A. Tetracyclines. Med. Clin. N. Am. 79:1995;789-801
26. Kroon A.M., Dontje B.H., Holtrop M., Van den Bogert C. The mitochondrial genetic system as a target for chemotherapy: tetracyclines as cytostatics. Cancer Lett. 25:1984;33-40
27. Lange M.S., Johnston M.V., Tseng E.E., Baumgartner W.A., Blue M.E. Apoptosis detection in brain using low-magnification dark-field microscopy. Exp. Neurol. 158:1999;254-260
28. Lin S., Zhang Y., Dodel R., Farlow M.R., Paul S.M., Du Y. Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons. Neurosci. Lett. 315:2001;61-64
29. Lin S., Wei X., Xu Y., Yan C., Dodel R., Zhang Y., Liu J., Klaunig J.E., Farlow M., Du Y. Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons. Life Sci. 72:2003;1635-1641
30. Nagarajan L., Lan G.C. Tetracycline-induced benign intracranial hypertension. J. Paediatr. Child Health. 36:2000;82-83
31. Nakajima W., Ishida A., Lange M.S., Gabrielson K.L., Wilson M.A., Martin L.J., Blue M.E., Johnston M.V. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J. Neurosci. 20:2000;7994-8004
32. Popovic N., Schubart A., Goetz B.D., Zhang S.C., Linington C., Duncan I.D. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann. Neurol. 51:2002;215-223
33. Sanchez Mejia R.O., Ona V.O., Li M., Friedlander R.M. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery. 48:2001;1393-1401
34. Smith D.L., Woodman B., Mahal A., Sathasivam K., Ghazi-Noori S., Lowden P.A.S., Bates G.P., Hockly E. Minocycline and doxycycline are not beneficial in a model of Huntington's disease. Ann. Neurol. 54:2003;186-196
35. Tamargo R.J., Bok R.A., Brem H. Angiogenesis inhibition by minocycline. Cancer Res. 51:1991;672-675
36. Tikka T.M., Koistinaho J.E. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 166:2001;7527-7533
37. Tikka T., Fiebich B.L., Goldsteins G., Keinänen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against exitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21:2001;2580-2588
38. Tikka T., Usenius T., Tenhunen M., Keinänen R., Koistinaho J. Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation. J. Neurochem. 78:2001;1409-1414
39. Tsuji M., Higuchi Y., Shiraishi K., Kume T., Akaike A., Hattori H. Protective effect of aminoguanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat. Pediatr. Res. 47:2000;79-83
40. Van den Bosch L., Tilkin P., Lemmens G., Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. NeuroReport. 13:2002;1067-1070
41. Wang C.X., Yang T., Noor R., Shuaib A. Delayed minocycline but not delayed mild hypothermia protects against embolic stroke. BMC Neurol. 2:2002;2
42. Wang C.X., Yang T., Shuaib A. Effects of minocycline alone and in combination with mild hypothermia in embolic stroke. Brain Res. 963:2003;327-329
43. Yang L., Sugama S., Chirichigno J.W., Gregorio J., Lorenzl S., Shin D.H., Browne S.E., Shimizu Y., Joh T.H., Beal M.F., Albers D.S. Minocycline enhances MPTP toxicity to dopaminergic neurons. J. Neurosci. Res. 74:2003;278-285
44. Yrjänheikki J., Keinänen R., Pellikka M., Hökfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15769-15774
45. Yrjänheikki J., Tikka T., Keinänen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U. S. A. 96:1999;13496-13500
46. Zhang W., Narayanan M., Friedlander R.M. Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS. Ann. Neurol. 53:2003;267-270
47. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y.S., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu D.C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 417:2002;74-78